In 2010, the Ginger Industry was successful in raising an R&D levy to help fund much-needed R&D, largely to meet the challenges of critical disease issues threatening the industry’s viability.
A subsequent, strongly supported vote, saw the statutory R&D levy introduced in April 2011. Since that time, the Ginger Industry R&D Program has developed as a cohesive set of projects managed through RIRDC.
This report outlines the R&D priorities and strategies over the next five years for the Ginger Industry. It builds on the outcomes of a series of stakeholder meetings conducted over the past three years where R&D priorities were sought, honed and prioritised by the industry’s stakeholders.